ISSN Print: 2381-103X  ISSN Online: 2381-1048
American Journal of Biomedical Science and Engineering  
Manuscript Information
 
 
Clinical Patterns and Early Prognosis of Stroke in Babol, Northern Iran
American Journal of Biomedical Science and Engineering
Vol.4 , No. 3, Publication Date: Aug. 10, 2018, Page: 30-35
1055 Views Since August 10, 2018, 420 Downloads Since Aug. 10, 2018
 
 
Authors
 
[1]    

Alijan Ahmadi Ahangar, Mobility Impairment Research Center, Babol University of Medical Sciences, Babol, Iran.

[2]    

Payam Saadat, Mobility Impairment Research Center, Babol University of Medical Sciences, Babol, Iran.

[3]    

Shayan Alijanpour, Critical Care Nursing, Student Research Committee, Isfahan University of Medical Science, Isfahan, Iran.

[4]    

Seyedeh Tahereh Taheri, Nursing Department, Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.

 
Abstract
 

Background: Stroke is the second leading cause of death worldwide. Data on the epidemiology of stroke, patterns and risk factors in recent years in our region are brief. Methods and Material: This retrospective study from 2014 to 2015 on stroke patients in Ayatollah Rouhani hospital in Babol was conducted. The MRS and Barthel index were used at admission and discharge of stroke patients. Patient’s demographic data and checklist used to identify stroke types, risk factors and early prognosis. Findings: A total of 230 patients were included in this study, 122 patients (53%) was female, 194 cases (%84) was ischemic type vs. 36 (%16) hemorrhagic, P<0001. The difference in underlying disease was statistically significant (168 patients (%73) Hypertension, 121 (%52.6) Diabetes Mellitus, 118 (%51.3) Cardiac Disease, 108 (%46.9) Hyperlipidemia, 58 (%25.2) Smoking and 46 patients (%20) had the Opioid addiction, P<0001). Hypertension was statistically significant and increased in hemorrhagic subtype (25 patient (%70) Intracerebral vs. 11 patient (%30) Subarachnoid, P=0.01). The difference in Cardiac disease (p<0.0001), Diabetes Mellitus (p<0.001), Smoking (p<0.001), Opioid Addiction (p<0.04) was statistically significant and increased in Intracerebral patients. Up to the first week of hospitalization, 10%of stroke patients (7% elderly, 3% non-elderly) were expired. Conclusions: Hypertension was most frequent stroke risk factor especially in Intracerebral Hemorrhage and male patients. High smoking was seen in Intracerebral Hemorrhage. The early mortality rate in stroke patients was low. It suggests that health ministry do screening plan in nonelderly, especially female, male with Hypertension and smoking consider as target population.


Keywords
 

Stroke, Ischemic Stroke, Hemorrhagic Stroke, Hypertension


Reference
 
[01]    

Feigin VL KR, Parmar P, Norrving B, Mensah GA, Bennett DA, et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 study. Neuroepidemiology. 2015; 28 (3): 161-76.

[02]    

Esenwa C, Gutierrez J. Secondary stroke prevention: challenges and solutions. Vascular Health and Risk Management. 2015; 11: 437-50.

[03]    

Daneshfard B, Izadi S, Shariat A, Toudaji MA, Beyzavi Z, Niknam L. Epidemiology of stroke in Shiraz, Iran. Iranian Journal of Neurology. 2015; 14 (3): 158-63.

[04]    

O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral hemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010: 112-23.

[05]    

Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G, et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008; 7 (10): 915-26.

[06]    

Romero JR, Morris J, Pikula A. Stroke prevention: modifying risk factors. Ther Adv Cardiovasc Dis. 2008; 2 (4): 287-303.

[07]    

Armin Grau CW, Florian Buggle, Alexander Heinrich, Michael Goertler, Stefan Neumaier, et al. Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke The German Stroke Data Bank. Stroke. 2001; 32: 2559-66.

[08]    

Ahangar AA, Ashraf Vaghefi SB, Ramzani M. Epidemiological evaluation of stroke in Babol, northern Iran. Eur Neurol. 2005; 54 (2): 93-7.

[09]    

Chong D, Aaron R, Steven N. Physical Activity and Stroke Risk A Meta-Analysis. Stroke. 2003; 34: 2475-82.

[10]    

Hosseini AA, Sobhani-Rad D, Ghandehari K, Benamer HT. Frequency and clinical patterns of stroke in Iran, Systematic and critical review. BMC Neurol 2010; 10 (72).

[11]    

Armin Grau, Christian Weimar, Florian Buggle, Alexander Heinrich, Michael Goertler, Stefan Neumaier, et al. Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke The German Stroke Data Bank. Stroke. 2001; 32: 2559-66.

[12]    

Harrison JK, McArthur KS, Quinn TJ. Assessment scales in stroke: clinometric and clinical considerations. Clinical Interventions in Aging. 2013; 8: 201-11.

[13]    

Kasper M, Fauci N, Hauser L, Longo F. Harrison’s principles of internal medicine. 19 edition, editor: Mc Graw Hill; 2015.

[14]    

Putaala J, Metso A, Metso T, Konkola N, Kraemer Y, Haapaniemi E. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki Young Stroke Registry. Stroke. 2009; 40: 1195-203.

[15]    

Chobanian AV, Bakris GL, Black HR. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42: 1206-52.

[16]    

Williams L. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002; 106 (25): 3143.

[17]    

Feigin VL, Krishnamurthi RV, Barker-Collo S, McPherson KM, Barber PA, Parag V. 30-Year Trends in Stroke Rates and Outcome in Auckland, New Zealand (1981-2012): A Multi-Ethnic Population-Based Series of Studies. PLOS ONE. 2015; 10 (8).

[18]    

Yoon SS, Heller RF, Levi C, Wiggers J, Fitzgerald PE. Knowledge of Stroke Risk Factors, Warning Symptoms, and Treatment Among an Australian Urban Population. Stroke. 2001; 32: 1926-30.

[19]    

Baghbanian SM, Ramezani M, Abedini M, Yazdani Charati J. Difference between Risk Factors of Common Ischemic Brain Strokes on Anterior and Posterior Circulation. Journal of Mazandaran University of Medical Sciences. 2013 Jun 15; 23 (101): 49-54.

[20]    

Howden LM, Meyer JA. Age and sex composition: 2010 Census Briefs. In: US Department of Commerce EaSA, editor. US Census Bureau 2010.

[21]    

Franconi F, Campesi I, Occhioni S, Tonolo G. Sex-gender differences in diabetes vascular complications and treatment. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2012; 12 (2): 179-96.

[22]    

Hosseini SR, Cumming RG, Kheirkhah F, Nooreddini H, Baiani M, Mikaniki E, et al. Cohort profile: The Amirkola health and aging project (AHAP). International journal of epidemiology. 2014; 43 (5): 1393-400.

[23]    

Azarpazhooh MR, Etemadi MM, Donnan GA, Mokhber N, Majdi MR, Ghayour-Mobarhan M. Excessive incidence of stroke in Iran: evidence from the Mashhad Stroke Incidence Study (MSIS), a population-based study of stroke in the Middle East. Stroke. 2010; 41 (1): 3-10.

[24]    

Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009; 40 (4): 1082-90.

[25]    

Ahangar AA, Saravi M, Alijanpour S, Boora MM, Hoseinalipour S, Zadeh HH, et al. Comparison of Risk Factors of Stroke and Myocardial Infarction in Patients 15 to 45 Years in Affiliated Hospitals of Babol University of Medical Sciences. Zahedan Journal of Research in Medical Sciences. 2016; 18 (12).

[26]    

Estol CJ, Rojas MM. Stroke in Argentina. Int J Stroke 2010; 5 (1): 35-9.

[27]    

Murray V, Norrving B, Sandercock PA, Terent A, Wardlaw JM, Wester P. The molecular basis of thrombolysis and its clinical application in stroke. J Intern Med. 2010; 267 (2): 191-208.

[28]    

Grysiewicz RA, Thomas K, Pandey DK. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol Clin 2008; 26 (4): 871-95.

[29]    

Wu L, Wang A, Wang X, Zhao X, Wang C, Liu L, et al. Factors for short-term outcomes in patients with a minor stroke: results from China National Stroke Registry. BMC Neurology. 2015; 15: 253.

[30]    

Chang WH, Park C-h, Kim DY, Shin Y-I, Ko M-H, Lee A, et al. Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke. BMC Neurology. 2016; 16 (31).

[31]    

Reimers CD, Knapp G, Reimers AK. Exercise as stroke prophylaxis. Dtsch Arztebl Int. 2009; 106 (44): 715-21.

[32]    

Sturgeon JD, Folsom AR, Longstreth W, Shahar E, Rosamond WD, Cushman M. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke. 2007; 38 (10): 2718-25.

[33]    

Fisher M. Stroke and TIA: epidemiology, risk factors, and the need for early intervention. Am J Manag Care. 2008; 14 (6): 5204-11.

[34]    

Khaw KT. Epidemiology of stroke. J Neurol Neurosurg Psychiatry 1996; 61 (4): 333-8.

[35]    

Barba R, Marco J, Ruiz J, Canora J, Hinojosa J, Plaza S, et al. The obesity paradox in stroke: impact on mortality and short-term readmission. Journal of Stroke and Cerebrovascular Diseases. 2015; 24 (4): 766-70.

[36]    

Luengo-Fernandez R, Paul NL, Gray AM, Pendlebury ST, Bull LM, Welch SJ, et al. Population-based study of disability and institutionalization after transient ischemic attack and stroke. Stroke. 2013; 44 (10): 2854-61.





 
  Join Us
 
  Join as Reviewer
 
  Join Editorial Board
 
share:
 
 
Submission
 
 
Membership